As filed with the Securities and Exchange Commission on November 28, 2012



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM N-Q
 
 
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT
INVESTMENT COMPANY



Investment Company Act file number 811-05469



The Wexford Trust
(Exact name of registrant as specified in charter)


5000 Stonewood Drive, Suite 300
Wexford, PA  15090-8388
(Address of principal executive offices) (Zip code)


Ronald H. Muhlenkamp
Muhlenkamp & Company, Inc.
5000 Stonewood Drive, Suite 300
Wexford, PA  15090-8388
(Name and address of agent for service)


(724) 935-5520 or (800) 860-3863
Registrant's telephone number, including area code



Date of fiscal year end: December 31, 2012


Date of reporting period:   September 30, 2012

 
 

 
 
Item 1. Schedule of Investments.
 
 
MUHLENKAMP FUND
 
(A Portfolio of the Wexford Trust)
 
SCHEDULE OF INVESTMENTS
 
September 30, 2012 (Unaudited)
 
Name of Issuer or Title of Issue
 
Shares
   
Value
 
COMMON STOCKS - 93.6%
           
Aerospace & Defense - 0.4%
           
Innovative Solutions & Support, Inc. (a)
    493,229     $ 1,963,051  
Airlines - 1.8%
               
Allegiant Travel Company (a)(c)
    131,200       8,312,832  
Auto Components - 1.3%
               
American Axle & Manufacturing Holdings, Inc. (a)(c)
    400,000       4,508,000  
Fuel Systems Solutions, Inc. (a)
    79,988       1,374,994  
              5,882,994  
Automobiles - 1.7%
               
Ford Motor Company
    789,000       7,779,540  
Biotechnology - 2.8%
               
Celgene Corporation (a)
    165,000       12,606,000  
Capital Markets - 3.6%
               
State Street Corporation
    390,568       16,388,233  
Commercial Banks - 1.4%
               
PNC Financial Services Group, Inc.
    100,000       6,310,000  
Diversified Financial Services - 5.7%
               
Citigroup Inc.
    300,000       9,816,000  
JPMorgan Chase & Co.
    407,000       16,475,360  
              26,291,360  
Diversified Telecommunication Services - 0.9%
               
AT&T, Inc.
    110,000       4,147,000  
Electronic Equipment, Instruments & Components - 2.2%
               
Corning, Inc.
    742,000       9,757,300  
Universal Display Corporation (a)(c)
    20,000       687,600  
              10,444,900  
Energy Equipment & Services - 3.8%
               
C&J Energy Services, Inc. (a)
    100,000       1,990,000  
Halliburton Company
    407,000       13,711,830  
Helix Energy Solutions Group, Inc. (a)(c)
    100,200       1,830,654  
              17,532,484  
Health Care Equipment & Supplies - 4.5%
               
Covidien PLC (b)
    345,000       20,499,900  
Health Care Providers & Services - 0.9%
               
Laboratory Corporation of America Holdings (a)
    42,500       3,929,975  
Household Durables - 1.8%
               
KB Home (c)
    190,000       2,726,500  
PulteGroup, Inc. (a)(c)
    300,000       4,650,000  
Stanley Furniture Co., Inc. (a)
    220,800       1,075,296  
              8,451,796  
Industrial Conglomerates - 2.7%
               
General Electric Company
    535,000       12,149,850  
Insurance - 9.0%
               
Aflac, Inc.
    225,000       10,773,000  
Berkshire Hathaway, Inc. - Class B (a)
    143,500       12,656,700  
Lincoln National Corporation
    300,000       7,257,000  
MetLife, Inc.
    300,000       10,338,000  
              41,024,700  
Internet Software & Services - 1.0%
               
Yahoo! Inc. (a)
    285,000       4,552,875  
IT Services - 5.0%
               
Alliance Data Systems Corporation (a)
    160,000       22,712,000  
Life Sciences Tools & Services - 2.1%
               
Life Technologies Corporation (a)
    195,000       9,531,600  
Machinery - 3.5%
               
Terex Corporation (a)(c)
    100,000       2,258,000  
Westport Innovations, Inc. (a)(b)
    500,000       13,920,000  
              16,178,000  
Oil, Gas & Consumable Fuels - 2.4%
               
Rex Energy Corporation (a)
    648,925       8,663,149  
SandRidge Energy, Inc. (a)(c)
    330,000       2,300,100  
              10,963,249  
Pharmaceuticals - 8.6%
               
Abbott Laboratories
    300,000       20,568,000  
Novogen Limited - ADR (a)
    32,914       62,207  
Pfizer, Inc.
    314,000       7,802,900  
Teva Pharmaceutical Industries Ltd. - ADR
    265,000       10,973,650  
              39,406,757  
Semiconductors & Semiconductor Equipment - 6.0%
               
Cypress Semiconductor Corporation
    275,000       2,948,000  
Intel Corporation
    966,000       21,908,880  
Lattice Semiconductor Corporation (a)
    667,300       2,555,759  
              27,412,639  
Software - 7.9%
               
Microsoft Corporation
    790,000       23,526,200  
Oracle Corporation
    400,000       12,596,000  
              36,122,200  
 
 
 

 
 
Specialty Retail - 5.2%
               
Asbury Automotive Group, Inc. (a)
    100,000       2,795,000  
Sonic Automotive, Inc. - Class A (c)
    1,100,000       20,878,000  
              23,673,000  
Tobacco - 5.7%
               
Philip Morris International, Inc.
    290,580       26,134,765  
Trading Companies & Distributors - 1.7%
               
Rush Enterprises, Inc. - Class A (a)
    379,907       7,317,009  
Rush Enterprises, Inc. - Class B (a)
    41,407       696,052  
              8,013,061  
Total Common Stocks
               
(Cost $358,835,960)
            428,414,761  
                 
   
Contracts
         
   
(100 Shares Per Contract)
         
PURCHASED CALL OPTIONS - 0.3%
               
Morgan Stanley
               
Expiration January 2014
               
Exercise Price $17.00
    4,000       1,132,000  
Total Purchased Call Options
               
(Cost $1,242,093)
            1,132,000  
                 
TOTAL INVESTMENTS
               
(Cost $360,078,053) - 93.9% (d)(e)
            429,546,761  
ASSETS IN EXCESS OF OTHER LIABILITIES - 6.1%
            27,964,571  
TOTAL NET ASSETS - 100.0%
          $ 457,511,332  


Percentages are stated as a percent of net assets.
ADR
American Depository Receipt
 
PLC
Public Limited Company
 
(a)
Non-income producing security.
 
(b)
Foreign company.
 
(c)
Shares are held as collateral for all or a portion of a corresponding written option contract. The value of the collateral
 
on September 30, 2012 was $48,151,686.
 
(d)
The cost basis of investments for federal income tax purposes at September 30, 2012 was as follows*:
 
 
 
Cost of investments
  $ 360,079,310  
 
Gross unrealized appreciation
    92,177,626  
 
Gross unrealized depreciation
    (22,710,175 )
 
Net unrealized appreciation
  $ 69,467,451  
           
 
*Because tax adjustments are calculated annually, the above table reflects the tax adjustments outstanding at the Fund’s previous fiscal year end. For the previous
 
fiscal year’s federal income tax information, please refer to the Notes to Financial Statements section in the Fund’s most recent semi-annual or annual report.
 
(e)
Investment Valuations - Stocks, bonds, options and warrants are valued at the latest sales price on the last business day of the fiscal period as reported by the
 
securities exchange on which the issue is traded. If no sale is reported, the security is valued at the last quoted bid price. Short-term debt instruments
 
(those with remaining maturities of 60 days or less) are valued at amortized cost, which approximates fair value. Restricted securities, private
 
placements, other illiquid securities and other securities for which market value quotations are not readily available are valued at fair value as
 
determined by a designated Valuation Committee, comprised of personnel of the Adviser, under the supervision of the Board of Trustees, in
 
accordance with pricing procedures approved by the Board. For each applicable investment that is fair valued, the Valuation Committee considers,
 
to the extent applicable, various factors including, but not limited to, the financial condition of the company or limited partnership, operating
 
results, prices paid in follow-on rounds, comparable companies in the public market, the nature and duration of the restrictions for holding the
 
securities, and other relevant factors.
   
 
Additionally, the Fund’s investments will be valued at fair value by the Valuation Committee if the Adviser determines that an event impacting the
 
value of an investment occurred between the closing time of a security’s primary market or exchange (for example, a foreign exchange or market)
 
and the time the Fund’s share price is calculated. Significant events include, but are not limited to the following: significant fluctuations in
 
domestic markets, foreign markets or foreign currencies; occurrences not directly tied to the securities markets such as natural disasters, armed
 
conflicts or significant governmental actions; and major announcements affecting a single issuer or an entire market or market sector. In
 
responding to a significant event, the Valuation Committee would determine the fair value of affected securities considering factors including, but
 
not limited to: index options and futures traded subsequent to the close; ADRs, GDRs or other related receipts; currency spot or forward markets
 
that trade after pricing of the foreign exchange; other derivative securities traded after the close such as WEBs and SPDRs; and alternative market
 
quotes on the affected securities.
   
 
The Fund performed an analysis of all existing investments to determine the significance and character of all inputs to their fair value
 
determination. Various inputs are used in determining the value of the Fund’s investments. These inputs are summarized in the three broad levels
 
listed below:
 
                        Summary of Fair Value Exposure at September 30, 2012
Level 1 - Quoted prices in active markets for identical securities.
             
Level 2 - Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
   
Level 3 - Significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments).
       
                 
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
   
                 
 
 
 

 
 
The following is a summary of the inputs used to value the Fund's net assets as of September 30, 2012:
       
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
Common Stocks*
  $ 428,414,761     $ -     $ -     $ 428,414,761  
Purchased Call Option Contracts
    -       1,132,000       -       1,132,000  
Total Investments in Securities
  $ 428,414,761     $ 1,132,000     $ -     $ 429,546,761  
                                 
Written Call Option Contracts
  $ 3,034,000     $ 1,709,400     $ -     $ 4,743,400  
                                 
 
* Please refer to the Schedule of Investments to view Common Stocks segregated by industry type.
         
                 
The Level 2 securities are priced using inputs such as last quoted bid, current yields, discount rates, credit quality, yields on computable securities, trading volume and maturity date.The Fund did not have any Level 3 investments at the end of the period. There were no transfers into or out of Level 1 or Level 2 during the period.
 
 
(f)
Fair values of derivative instruments as of September 30, 2012:
                       
     
Asset Derivatives
   
Liability Derivatives
 
 
Derivatives
 
Description
   
Fair Value
   
Description
   
Fair Vaule
 
 
Equity Contracts:
                       
 
   Purchased Call Options
 
Schedule of Investments
    $ 1,132,000       N/A     $ -  
 
   Written Call Options
    N/A       -    
Schedule of Written Call Options
    4,743,400  
 
Total
          $ 1,132,000             $ 4,743,400  
                                   
 
The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of MSCI, Inc. and Standard & Poor Financial Services LLC ("S&P"). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp Funds Services, LLC.
 
 
 

 
 
 

 

MUHLENKAMP FUND
 
(A Portfolio of the Wexford Trust)
 
SCHEDULE OF WRITTEN OPTIONS
 
September 30, 2012 (Unaudited)
 
   
Contracts
       
Name of Issuer or Title of Issue
 
(100 Shares Per Contract)
   
Value
 
WRITTEN CALL OPTIONS - (1.0)%
           
Allegiant Travel Company
           
Expiration: October 2012, Exercise Price: $65.00
    400     $ 42,000  
American Axle & Manufacturing Holdings, Inc.
               
Expiration: October 2012, Exercise Price: $11.00
    1,000       69,000  
Expiration: January 2013, Exercise Price: $12.50
    1,000       65,000  
Helix Energy Solutions Group, Inc.
               
Expiration: January 2013, Exercise Price: $17.50
    1,000       195,000  
KB Home
               
Expiration: January 2014, Exercise Price: $10.00
    1,900       940,500  
PulteGroup, Inc.
               
Expiration: January 2013, Exercise Price: $7.50
    2,000       1,618,000  
Expiration: January 2014, Exercise Price: $10.00
    1,000       686,000  
SandRidge Energy, Inc.
               
Expiration: December 2012, Exercise Price: $7.00
    1,000       56,000  
Expiration: January 2014, Exercise Price: $10.00
    1,300       88,400  
Sonic Automotive, Inc. - Class A
               
Expiration: November 2012, Exercise Price: $17.50
    2,000       360,000  
Terex Corporation
               
Expiration: January 2013, Exercise Price: $17.50
    1,000       605,000  
Universal Display Corporation
               
Expiration: December 2012, Exercise Price: $39.00
    100       18,500  
Total Written Call Options
               
(Premiums received $2,399,238)
          $ 4,743,400  
                 


 
 
 

 
 
Item 2. Controls and Procedures.
 
(a)  
The Registrant’s President and Treasurer have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “1940 Act”)) (17 CFR 270.30a-3(c)) are effective as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rule 13a-15(b) or Rule 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(d)) .

(b)  
There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) (17 CFR 270.30a-3(d)) that occurred during the Registrant's last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.


Item 3. Exhibits.
 
Separate certifications for each principal executive officer and principal financial officer of the Registrant as required by Rule 30a-2(a) under the 1940 Act (17 CFR 270.30a-2(a)).   Filed herewith.
 

 
 

 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


(Registrant)   The Wexford Trust                                                                                 

 
By (Signature and Title)     /s/ Ronald H. Muhlenkamp                                            
Ronald H. Muhlenkamp, President

Date              11/19/2012                                                                                                   



Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)*    /s/ Ronald H. Muhlenkamp                                          
 Ronald H. Muhlenkamp, President

Date              11/19/2012                                                                                                   

 
By (Signature and Title)*         /s/ James S. Head                                                       
 James S. Head, Treasurer

Date              11/19/2012                                                                                                   

* Print the name and title of each signing officer under his or her signature.

 

Amerigroup (NYSE:AGP)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Amerigroup.
Amerigroup (NYSE:AGP)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Amerigroup.